1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Corneal Neovascularization Global Clinical Trials Review, H2, 2015

Corneal Neovascularization Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Corneal Neovascularization Global Clinical Trials Review, H2, 2015" provides an overview of Corneal Neovascularization clinical trials scenario. This report provides top line data relating to the clinical trials on Corneal Neovascularization. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Corneal Neovascularization Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Corneal Neovascularization 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Corneal Neovascularization to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Corneal Neovascularization to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Corneal Neovascularization 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Corneal Neovascularization Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Gene Signal International SA 31
Clinical Trial Overview of Gene Signal International SA 31
Regeneron Pharmaceuticals, Inc. 32
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 32
Ohr Pharmaceutical Inc. 33
Clinical Trial Overview of Ohr Pharmaceutical Inc. 33
Lux Biosciences, Inc. 34
Clinical Trial Overview of Lux Biosciences, Inc. 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Eyetech Pharmaceuticals, Inc. 36
Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 36
Elman Retina Group, P.A. 37
Clinical Trial Overview of Elman Retina Group, P.A. 37
Asociacion para Evitar la Ceguera en Mexico I.A.P. 38
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 38
Clinical Trial Overview of Top Institutes / Government 39
Massachusetts Eye and Ear Infirmary 39
Clinical Trial Overview of Massachusetts Eye and Ear Infirmary 39
Les Laboratoires CTRS 40
Clinical Trial Overview of Les Laboratoires CTRS 40
The University of Utah 41
Clinical Trial Overview of The University of Utah 41
Agostino Gemelli University Polyclinic 42
Clinical Trial Overview of Agostino Gemelli University Polyclinic 42
Arcispedale Santa Maria Nuova 43
Clinical Trial Overview of Arcispedale Santa Maria Nuova 43
Bascom Palmer Eye Institute 44
Clinical Trial Overview of Bascom Palmer Eye Institute 44
Chang Gung Memorial Foundation 45
Clinical Trial Overview of Chang Gung Memorial Foundation 45
Chonnam National University Hospital 46
Clinical Trial Overview of Chonnam National University Hospital 46
Ehime University Graduate School of Medicine 47
Clinical Trial Overview of Ehime University Graduate School of Medicine 47
Federal University of Sao Paulo 48
Clinical Trial Overview of Federal University of Sao Paulo 48
Five Key Clinical Profiles 49
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 72

List of Tables
Corneal Neovascularization Therapeutics, Global, Clinical Trials by Region, 2015* 7
Corneal Neovascularization Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Corneal Neovascularization Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Corneal Neovascularization Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Corneal Neovascularization Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Corneal Neovascularization Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Corneal Neovascularization Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Corneal Neovascularization to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Corneal Neovascularization Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Corneal Neovascularization Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Corneal Neovascularization to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Corneal Neovascularization Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Corneal Neovascularization Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Corneal Neovascularization Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Corneal Neovascularization Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Corneal Neovascularization Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Corneal Neovascularization Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Corneal Neovascularization Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Corneal Neovascularization Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Corneal Neovascularization Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Corneal Neovascularization Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Corneal Neovascularization Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Corneal Neovascularization Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Corneal Neovascularization Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Gene Signal International SA, 2015* 31
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 32
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohr Pharmaceutical Inc., 2015* 33
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Lux Biosciences, Inc., 2015* 34
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2015* 36
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Elman Retina Group, P.A., 2015* 37
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2015* 38
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts Eye and Ear Infirmary, 2015* 39
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Laboratoires CTRS, 2015* 40
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2015* 41
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Agostino Gemelli University Polyclinic, 2015* 42
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Arcispedale Santa Maria Nuova, 2015* 43
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Bascom Palmer Eye Institute, 2015* 44
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2015* 45
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Chonnam National University Hospital, 2015* 46
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Ehime University Graduate School of Medicine, 2015* 47
Corneal Neovascularization Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 48

List of Figures
Corneal Neovascularization Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Corneal Neovascularization Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Corneal Neovascularization Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Corneal Neovascularization Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Corneal Neovascularization Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Corneal Neovascularization Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Corneal Neovascularization to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Corneal Neovascularization Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Corneal Neovascularization Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Corneal Neovascularization to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Corneal Neovascularization Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Corneal Neovascularization Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Corneal Neovascularization Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Corneal Neovascularization Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Corneal Neovascularization Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Corneal Neovascularization Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Corneal Neovascularization Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Corneal Neovascularization Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Corneal Neovascularization Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Corneal Neovascularization Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.